Artwork

Content provided by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

R&D Costs, Rx Prices, and the Formula for Success in Life Sciences Innovation, With Stephen Ezell

27:55
 
Share
 

Manage episode 307195400 series 2676306
Content provided by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

The United States is the leader in life sciences innovation, but that has not always been the case. As global competition intensifies, it needs to continue spurring investment in R&D to stay on top. Rob and Jackie sat down with Stephen Ezell, vice president of global innovation policy at ITIF, to discuss the history of U.S. life sciences innovation and break down R&D costs versus the market prices of innovative biopharmaceuticals.
Mentioned

Related

  continue reading

102 episodes

Artwork
iconShare
 
Manage episode 307195400 series 2676306
Content provided by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

The United States is the leader in life sciences innovation, but that has not always been the case. As global competition intensifies, it needs to continue spurring investment in R&D to stay on top. Rob and Jackie sat down with Stephen Ezell, vice president of global innovation policy at ITIF, to discuss the history of U.S. life sciences innovation and break down R&D costs versus the market prices of innovative biopharmaceuticals.
Mentioned

Related

  continue reading

102 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play